Valuation: Alembic Pharmaceuticals Limited

Market Cap 162B 1.69B 1.45B 1.35B 1.24B 2.32B 2.36B 15.99B 6.23B 81.14B 6.34B 6.2B 268B P/E 2027 *
22.2x
P/E 2028 * 17.1x
Enterprise Value 172B 1.8B 1.54B 1.44B 1.32B 2.47B 2.51B 17.02B 6.64B 86.39B 6.75B 6.6B 286B EV / Sales 2027 *
2.04x
EV / Sales 2028 * 1.77x
Free-Float
29.33%
Yield 2027 *
1.57%
Yield 2028 * 1.86%
1 day+0.94%
1 week-1.14%
Current month+3.10%
1 month+1.18%
3 months+8.74%
6 months+7.69%
Current year-2.88%
1 week 806.25
Extreme 806.25
838
1 month 787.4
Extreme 787.4
855.9
Current year 635.8
Extreme 635.8
855.9
1 year 635.8
Extreme 635.8
998
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 2025-07-06
Compliance Officer - 2026-08-19
Chief Operating Officer - 2025-07-20
Director TitleAgeSince
Chairman 78 2012-06-07
Director/Board Member 50 2006-12-31
Director/Board Member 66 2003-01-17
Date Insider Type Main position Quantity % Market Cap.
3/28/25
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
3/24/25
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
3/21/25 Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+0.94%-1.14%-15.68%+7.36% 1.69B
+0.88%+6.38%+76.40%+126.75% 1,119B
+1.07%+3.80%+50.73%+62.78% 651B
+1.20%+6.21%+25.81%+78.74% 468B
+1.02%+5.77%+43.63%+48.43% 374B
+0.85%+4.07%+24.97%+40.58% 302B
+1.26%+6.81%+2.27%+14.41% 259B
+1.88%+5.81%+49.57%+70.53% 238B
+1.59%+2.09%-17.33%-52.62% 208B
+1.87%+5.61%+27.32%+91.38% 181B
Average +1.26%+4.36%+26.77%+48.83% 380.15B
Weighted average by Cap. +1.14%+5.09%+44.23%+72.62%

Financials

2027 *2028 *
Net sales 84.17B 880M 754M 705M 645M 1.21B 1.23B 8.33B 3.25B 42.28B 3.3B 3.23B 140B 92.45B 966M 828M 774M 709M 1.33B 1.35B 9.15B 3.57B 46.44B 3.63B 3.55B 154B
Net income 7.32B 76.5M 65.53M 61.31M 56.12M 105M 107M 724M 282M 3.68B 287M 281M 12.16B 9.48B 99.05M 84.84M 79.39M 72.67M 136M 138M 938M 366M 4.76B 372M 364M 15.75B
Net Debt 10.45B 109M 93.56M 87.54M 80.14M 150M 152M 1.03B 403M 5.25B 410M 401M 17.36B 1.91B 20.01M 17.14M 16.04M 14.68M 27.56M 27.92M 190M 73.9M 962M 75.15M 73.51M 3.18B
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
26-08-21 ₹821.75 +0.94% 35,565
26-08-20 ₹814.10 -0.42% 47,603
26-08-19 ₹817.50 -0.86% 98,543
26-08-18 ₹824.55 +0.26% 51,271
26-08-17 ₹822.45 -1.06% 90,276
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
821.75INR
Average target price
949.30INR
Spread / Average Target
+15.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock